Aker BioMarine Past Earnings Performance
Past criteria checks 0/6
Aker BioMarine has been growing earnings at an average annual rate of 28.6%, while the Food industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 1.6% per year.
Key information
28.6%
Earnings growth rate
43.5%
EPS growth rate
| Food Industry Growth | 3.2% |
| Revenue growth rate | 1.6% |
| Return on equity | -8.2% |
| Net Margin | -7.2% |
| Next Earnings Update | 03 Apr 2025 |
Recent past performance updates
Recent updates
Is Aker BioMarine (OB:AKBM) Using Too Much Debt?
Feb 15
Aker BioMarine AS' (OB:AKBM) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Dec 20Aker BioMarine (OB:AKBM) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 08Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors
Nov 05At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?
Aug 20Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking
Jul 19What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates
Jul 16There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital
Jul 11These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way
Jun 03There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues
Feb 15There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital
Nov 06Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)
Sep 06We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings
Nov 04Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability
Apr 13Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Feb 18Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven
Jan 07Revenue & Expenses Breakdown
How Aker BioMarine makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 24 | 199 | -14 | 61 | 0 |
| 30 Sep 24 | 335 | 3 | 89 | 0 |
| 30 Jun 24 | 338 | -11 | 89 | 0 |
| 31 Mar 24 | 336 | -8 | 89 | 0 |
| 31 Dec 23 | 335 | -9 | 91 | 0 |
| 30 Sep 23 | 227 | -15 | 67 | 0 |
| 30 Jun 23 | 242 | 0 | 75 | 0 |
| 31 Mar 23 | 268 | 14 | 83 | 0 |
| 31 Dec 22 | 277 | 10 | 87 | 0 |
| 30 Sep 22 | 274 | 1 | 90 | 0 |
| 30 Jun 22 | 268 | 10 | 88 | 0 |
| 31 Mar 22 | 269 | -8 | 88 | 0 |
| 31 Dec 21 | 262 | -8 | 84 | 0 |
| 30 Sep 21 | 262 | 3 | 91 | 0 |
| 30 Jun 21 | 270 | -8 | 84 | 0 |
| 31 Mar 21 | 268 | -14 | 87 | 0 |
| 31 Dec 20 | 289 | -5 | 87 | 0 |
| 30 Sep 20 | 285 | -26 | 77 | 0 |
| 30 Jun 20 | 284 | -28 | 83 | 0 |
| 31 Mar 20 | 278 | -18 | 77 | 0 |
| 31 Dec 19 | 246 | -24 | 72 | 0 |
| 31 Dec 18 | 154 | -1 | 45 | 0 |
| 31 Dec 17 | 126 | -18 | 33 | 0 |
| 30 Sep 17 | 123 | -15 | 35 | 0 |
| 30 Jun 17 | 122 | -11 | 34 | 0 |
| 31 Mar 17 | 119 | -5 | 32 | 0 |
| 31 Dec 16 | 117 | -2 | 30 | 0 |
| 30 Sep 16 | 111 | -8 | 25 | 0 |
| 30 Jun 16 | 110 | 0 | 23 | 0 |
| 31 Mar 16 | 109 | -3 | 23 | 0 |
| 31 Dec 15 | 105 | 1 | 23 | 0 |
| 30 Sep 15 | 105 | -5 | 23 | 0 |
| 30 Jun 15 | 103 | -14 | 24 | 0 |
| 31 Mar 15 | 111 | -13 | 24 | 0 |
| 31 Dec 14 | 112 | -17 | 26 | 0 |
| 30 Sep 14 | 99 | -34 | 11 | 0 |
| 30 Jun 14 | 109 | 44 | 4 | 0 |
| 31 Mar 14 | 106 | 43 | 4 | 0 |
Quality Earnings: AKBM is currently unprofitable.
Growing Profit Margin: AKBM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AKBM is unprofitable, but has reduced losses over the past 5 years at a rate of 28.6% per year.
Accelerating Growth: Unable to compare AKBM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AKBM is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (39.9%).
Return on Equity
High ROE: AKBM has a negative Return on Equity (-8.22%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/15 17:00 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Aker BioMarine AS is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Ola Trovatn | DNB Markets |
| Carl-Emil Johannessen | Pareto Securities |